EICHOR
● Completed
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab
Condition: HIV Infections · Multi-Antiviral Resistance · Sponsor: Theratechnologies
About this study
The virological efficacy of ibalizumab has been clearly demonstrated in multiple clinical trials. This study will expand ibalizumab's clinical data set and allow a better understanding of the virologic response durability on ARV regimens with or without ibalizumab in a heterogeneous real-world patient population. Additional data on the efficacy and safety of ibalizumab and its impact on patient reported outcomes will be captured until study end. Primary Objective: To evaluate the long-term efficacy, safety, and durability of ibalizumab in combination with other ARVs by comparing the virologic, immunologic and clinical outcomes of patients receiving ibalizumab treatment versus patients not receiving ibalizumab. Secondary Objective: To assess the efficacy of ibalizumab in combination with other antiretrovirals by comparing the virologic, immunologic, clinical and patient reported outcomes of patients before and after they receive ibalizumab treatment. To assess the long-term safety and tolerability of ibalizumab. Other Objectives: To assess risk factors/predictors of virologic and immunologic response. To assess efficacy and safety in special populations that enroll.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (36)
| Ruane Clinical Research | Los Angeles, California, United States | — |
| Mills Clinical Research | Los Angeles, California, United States | — |
| BIOS Clinical Research | Palm Springs, California, United States | — |
| UC San Diego Owen Clinic | San Diego, California, United States | — |
| Yale University | New Haven, Connecticut, United States | — |
| Circle Care Center | Stamford, Connecticut, United States | — |
| Waterbury Hospital | Waterbury, Connecticut, United States | — |
| Whitman Walker Health | Washington D.C., District of Columbia, United States | — |
| Georgetown University Medical Center | Washington D.C., District of Columbia, United States | — |
| Aids Healthcare Foundation | Fort Lauderdale, Florida, United States | — |
| Gary J. Richmond, M.D., PA | Fort Lauderdale, Florida, United States | — |
| Midway Specialty Care Center Miami Beach | Miami Beach, Florida, United States | — |
+ 24 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05388474